Such an inhibition limits the available C3 molecules for further incorporation into the C5 convertase assembly, thereby preventing the formation and in situ deposition of MAC, as confirmed in the repeated muscle biopsy specimens of dermatomyositis patients treated with IVIg [46, 47]. This evidence concerns the gene C3 and dermatomyositis.